Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $5.2M | 3 | 99.5% |
| Travel and Lodging | $13,176 | 18 | 0.3% |
| Consulting Fee | $12,070 | 3 | 0.2% |
| Food and Beverage | $248.96 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Asklepios Biopharmaceutical Inc. | $4.5M | 2 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $619,723 | 3 | $0 (2022) |
| AstraZeneca AB | $14,538 | 12 | $0 (2017) |
| BAMBOO THERAPEUTICS, INC. | $8,070 | 2 | $0 (2018) |
| ABIOMED | $1,782 | 10 | $0 (2019) |
| PFIZER INC. | $858.06 | 2 | $0 (2018) |
| GE HEALTHCARE | $206.86 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2.1M | 1 | Asklepios Biopharmaceutical Inc. ($2.1M) |
| 2023 | $2.4M | 1 | Asklepios Biopharmaceutical Inc. ($2.4M) |
| 2022 | $619,683 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($619,683) |
| 2019 | $731.75 | 4 | ABIOMED ($731.75) |
| 2018 | $9,560 | 7 | BAMBOO THERAPEUTICS, INC. ($8,070) |
| 2017 | $15,203 | 18 | AstraZeneca AB ($14,538) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Asklepios Biopharmaceutical Inc. | — | Acquisitions | Cash or cash equivalent | $2,114,077.40 | General |
| 12/29/2023 | Asklepios Biopharmaceutical Inc. | — | Acquisitions | Cash or cash equivalent | $2,429,895.47 | General |
| 12/29/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Acquisitions | Cash or cash equivalent | $619,683.10 | General |
| 02/02/2019 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $177.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/31/2019 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $201.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/18/2019 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $331.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/18/2019 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2018 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $212.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2018 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $214.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2018 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $207.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2018 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/07/2018 | PFIZER INC. | — | Travel and Lodging | Cash or cash equivalent | $835.15 | General |
| 01/15/2018 | BAMBOO THERAPEUTICS, INC. | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| 01/15/2018 | BAMBOO THERAPEUTICS, INC. | — | Consulting Fee | Cash or cash equivalent | $2,070.00 | General |
| 12/13/2017 | GE HEALTHCARE | CARDIOVASCULAR DISEASE (Device) | Travel and Lodging | Cash or cash equivalent | $206.86 | General |
| Category: GLOBAL MARKETING | ||||||
| 12/13/2017 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $22.91 | General |
| 11/13/2017 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $17.13 | General |
| 10/11/2017 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $212.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2017 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $182.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/21/2017 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Cardio-pulmonary | ||||||
| 02/06/2017 | AstraZeneca AB | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 02/06/2017 | AstraZeneca AB | — | Travel and Lodging | In-kind items and services | $105.00 | General |
| 01/31/2017 | AstraZeneca AB | — | Travel and Lodging | In-kind items and services | $68.89 | General |
| 01/31/2017 | AstraZeneca AB | — | Food and Beverage | In-kind items and services | $32.36 | General |
| 01/30/2017 | AstraZeneca AB | — | Travel and Lodging | In-kind items and services | $150.30 | General |
About Dr. Roger Hajjar, MD
Dr. Roger Hajjar, MD is a Cardiovascular Disease healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003801903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Hajjar, MD has received a total of $5.2M in payments from pharmaceutical and medical device companies, with $2.1M received in 2024. These payments were reported across 32 transactions from 7 companies. The most common payment nature is "Acquisitions" ($5.2M).
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Specialist
- Location New York, NY
- Active Since 09/16/2005
- Last Updated 02/09/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003801903
Products in Payments
- Impella (Device) $1,782
- CARDIOVASCULAR DISEASE (Device) $206.86
- Adempas (Drug) $23.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New York
Dr. Jacob Koruth, M.d, M.D
Cardiovascular Disease — Payments: $3.2M
Dr. Martin Leon, M.d, M.D
Cardiovascular Disease — Payments: $2.7M
Dr. Gregg Stone, M.d, M.D
Cardiovascular Disease — Payments: $2.2M
Adam Rosenbluth, Md, MD
Cardiovascular Disease — Payments: $1.5M
Dr. Deepak Bhatt, Md, MD
Cardiovascular Disease — Payments: $1.4M
Dr. Philippe Genereux, M.d, M.D
Cardiovascular Disease — Payments: $1.1M